Interestingly, a study in multiple myeloma (MM) verified that the transfer of exosomal lncRUNX2-AS1 from MM cells to mesenchymal stem/stromal cells can inhibit the osteogenesis via the exosomal lncRUNX2-AS1/RUNX2 pathway37. Here, RUNX2 is linked to Miyoshi myopathy.